hyperlipidemias/カリウム

FIELD OF THE INVENTION The present invention relates to solid forms of atorvastatin potassium and novel processes for preparing said solid forms of atorvastatin potassium. BACKGROUND OF THE INVENTION Atorvastatin, ([R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl-

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is directed toward a novel process by which the salts of (-)-hydroxycitric acid, either potassium (-)-hydroxycitrate, the preferred salt of (-)-hydroxycitric acid, or, alternatively, sodium (-)-hydroxycitrate, can be rendered

The present invention relates to novel mevalonolactones having a quinoline ring, processes for their production, pharmaceutical compositions containing them and their pharmaceutical uses particularly as anti-hyperlipidemic, hypolipoproteinemic and anti-antherosclerotic agents, and intermediates

The present invention relates to novel mevalonolactones having a quinoline ring, processes for their production, pharmaceutical compositions containing them and their pharmaceutical uses particularly as anti-hyperlipidemic, hypolipoproteinemic and anti-atherosclerotic agents, and intermediates

FIELD OF THE INVENTION This invention relates generally to a weight control product that is administered enterally to mammals in need of losing weight and/or reducing the blood plasma lipid levels. The weight control product comprises a mixture of guggul extract and phosphate salts. The inventive

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to therapeutic systems and methods for dietary health management, i.e., the prevention, treatment, or reduction of risk factors associated with diet-responsive conditions, or a combination thereof. In particular,

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to therapeutic systems and methods for dietary health management, i.e., the prevention, treatment, or reduction of risk factors associated with diet-responsive conditions, or a combination thereof. In particular,

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is directed toward a novel process by which hygroscopic salts of (-)-hydroxycitric acid, either potassium (-)-hydroxycitrate, the preferred salt of (-)-hydroxycitric acid, or, alternatively, sodium or other hygroscopic salts of